These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37594060)

  • 21. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
    Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
    Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
    Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
    Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study.
    Schrauwen W; Van de Cavey J; Vingerhoets G; Vanheule S; Van den Broecke R; Denys H
    J Int Neuropsychol Soc; 2020 Sep; 26(8):806-814. PubMed ID: 32312360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis-related cognitive impairment: a prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study.
    Bar-Sela G; Tauber D; Mitnik I; Sheinman-Yuffe H; Bishara-Frolova T; Aharon-Peretz J
    Anticancer Drugs; 2019 Jan; 30(1):91-97. PubMed ID: 30540595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of chemotherapy and subjective cognitive impairment in breast cancer patients: Meta-analysis of longitudinal prospective cohort studies.
    Kim HJ; Jung SO; Kim E; Abraham I
    Eur J Oncol Nurs; 2022 Apr; 57():102099. PubMed ID: 35255262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
    Ng T; Phey XY; Yeo HL; Shwe M; Gan YX; Ng R; Ho HK; Chan A
    Clin Breast Cancer; 2018 Oct; 18(5):e927-e937. PubMed ID: 29705024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy-related cognitive impairment (CRCI) among early-stage breast cancer survivors in Malaysia.
    Syed Alwi SM; Narayanan V; Mohd Taib NA; Che Din N
    J Clin Exp Neuropsychol; 2021 Jul; 43(5):534-545. PubMed ID: 34369307
    [No Abstract]   [Full Text] [Related]  

  • 28. Study of Chemotherapy-Induced Cognitive Impairment in Women with Breast Cancer.
    Rodríguez Martín B; Fernández Rodríguez EJ; Rihuete Galve MI; Cruz Hernández JJ
    Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33265966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
    Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
    J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.
    Vardy JL; Dhillon HM; Pond GR; Rourke SB; Bekele T; Renton C; Dodd A; Zhang H; Beale P; Clarke S; Tannock IF
    J Clin Oncol; 2015 Dec; 33(34):4085-92. PubMed ID: 26527785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients.
    Hermelink K; Bühner M; Sckopke P; Neufeld F; Kaste J; Voigt V; Münzel K; Wuerstlein R; Ditsch N; Hellerhoff K; Rjosk-Dendorfer D; Braun M; von Koch FE; Härtl K; Hasmüller S; Bauerfeind I; Debus G; Herschbach P; Mahner S; Harbeck N
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A Structural Model for Chemotherapy Related Cognitive Impairment and Quality of Life in Breast Cancer Patients].
    Lee JR; Oh PJ
    J Korean Acad Nurs; 2019 Aug; 49(4):375-385. PubMed ID: 31477668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.
    Li W; Zhao J; Ding K; Chao HH; Li CR; Cheng H; Shen L
    Med Sci Monit; 2020 Sep; 26():e923567. PubMed ID: 32985495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial.
    Milbury K; Chaoul A; Biegler K; Wangyal T; Spelman A; Meyers CA; Arun B; Palmer JL; Taylor J; Cohen L
    Psychooncology; 2013 Oct; 22(10):2354-63. PubMed ID: 23657969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.
    Ahles TA; Saykin AJ; McDonald BC; Li Y; Furstenberg CT; Hanscom BS; Mulrooney TJ; Schwartz GN; Kaufman PA
    J Clin Oncol; 2010 Oct; 28(29):4434-40. PubMed ID: 20837957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects.
    Nakamura ZM; Deal AM; Park EM; Stanton KE; Lopez YE; Quillen LJ; O'Hare Kelly E; Heiling HM; Nyrop KA; Ray EM; Dees EC; Reeder-Hayes KE; Jolly TA; Carey LA; Abdou Y; Olajide OA; Rauch JK; Joseph R; Copeland A; McNamara MA; Ahles TA; Muss HB
    Cancer Med; 2023 Apr; 12(7):8172-8183. PubMed ID: 36645168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
    Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
    J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
    Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
    Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study.
    Chen BT; Jin T; Patel SK; Ye N; Ma H; Wong CW; Rockne RC; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Li D; Sedrak MS; Vazquez J; Katheria V; Dale W
    Breast Cancer Res Treat; 2019 Jul; 176(1):181-189. PubMed ID: 30989462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.